Zollinger‑Ellison Gastric Pain: A Comprehensive Guide

What is Zollinger‑Ellison gastric pain?

Zollinger‑Ellison gastric pain is the abdominal discomfort that results from a rare, hormone‑producing tumor called a Zollinger‑Ellison syndrome (ZES) gastrinoma. Gastrinomas secrete excessive amounts of the hormone gastrin, which overstimulates the stomach’s acid‑producing cells. The resulting hyperacidity damages the lining of the stomach and duodenum, leading to ulcerations and the characteristic burning or gnawing pain that patients describe as “gastric pain.”

While the pain itself is a symptom, it is a clue that a potentially serious underlying condition is present. ZES accounts for only about 0.1 % of all peptic ulcer disease cases, but it carries a higher risk of ulcer complications, gastrointestinal bleeding, and, in some cases, pancreatic or duodenal cancer ^[1].

Common Causes

Gastric pain that mimics Zollinger‑Ellison syndrome can arise from several other conditions. Knowing these helps clinicians decide which tests are necessary.

• Peptic ulcer disease (PUD) – most common cause of epigastric pain; often linked to H. pylori infection or NSAID use.
• Gastric adenocarcinoma – malignant tumors may cause persistent pain and weight loss.
• Gastro‑esophageal reflux disease (GERD) – acid reflux can produce a burning sensation similar to ZES pain.
• Pancreatic neuroendocrine tumors (PNETs) – other hormone‑secreting tumors that can cause abdominal pain.
• Functional dyspepsia – non‑ulcer dyspepsia with vague epigastric discomfort.
• Chronic gastritis – inflammation from H. pylori, autoimmune disease, or irritants.
• Helicobacter pylori infection – a leading cause of ulcer disease and associated pain.
• Medication‑induced gastritis – NSAIDs, aspirin, corticosteroids, and bisphosphonates.
• Gastric volvulus or obstruction – mechanical causes that impair gastric emptying.
• Acute pancreatitis – can present with epigastric pain radiating to the back, sometimes confused with ZES.

Associated Symptoms

Because excess gastrin drives acid production, patients with Zollinger‑Ellison syndrome often experience a cluster of related signs and symptoms:

• Burning or gnawing epigastric pain, often worse 1‑3 hours after meals or at night
• Recurrent or refractory peptic ulcers (multiple sites, especially beyond the duodenal bulb)
• Frequent diarrhea or steatorrhea (fatty stools) due to acid inactivation of pancreatic enzymes
• Nausea and occasional vomiting, sometimes with blood (hematemesis)
• Weight loss despite normal or increased appetite
• Heartburn or acid reflux symptoms
• Signs of anemia (fatigue, pallor) from chronic bleeding
• Abdominal bloating or distention

When ZES occurs as part of the hereditary multiple endocrine neoplasia type 1 (MEN 1) syndrome, patients may also have symptoms of hyperparathyroidism (kidney stones, bone pain) or pituitary adenomas (headaches, visual changes) ^[2].

When to See a Doctor

Prompt medical evaluation is essential if any of the following appear:

• Severe, persistent epigastric pain that does not improve with over‑the‑counter antacids.
• Recurrent ulcers that heal and then return, especially after a short course of therapy.
• Unexplained weight loss or loss of appetite.
• Black, tarry stools (melena) or bright red blood per rectum.
• Vomiting of material that looks like coffee grounds (indicative of digested blood).
• Persistent diarrhea (>3‑4 watery stools per day) or greasy stools.
• Family history of MEN 1 or known gastrin‑producing tumors.

These signs suggest either an aggressive ulcer process or a possible tumor that needs to be identified early.

Diagnosis

Because Zollinger‑Ellison syndrome is rare and its symptoms overlap with common GI disorders, a systematic approach is required.

1. Clinical Evaluation

• Detailed medical history, including NSAID use, H. pylori status, and family history of endocrine tumors.
• Physical exam focusing on abdominal tenderness, signs of anemia, or palpable masses.

2. Laboratory Tests

• Fasting serum gastrin level – markedly elevated (>1000 pg/mL) in >70 % of ZES patients. Levels may be modestly raised in atrophic gastritis, so an acidic gastric pH is needed for interpretation.
• Gastric pH measurement – a pH < 2 confirms acid hypersecretion.
• Complete blood count (CBC) for anemia.
• Serum calcium & parathyroid hormone (PTH) if MEN 1 is suspected.

3. Imaging Studies

• Endoscopic ultrasound (EUS) – highly sensitive for locating small gastrinomas in the pancreas or duodenum.
• Contrast‑enhanced CT or MRI – delineates tumor size, local invasion, and distant metastasis.
• Somatostatin receptor scintigraphy (Octreoscan) or 68Ga‑DOTATATE PET/CT – detects neuroendocrine tumors that express somatostatin receptors.

4. Endoscopy

Upper gastrointestinal endoscopy (EGD) reveals ulceration patterns typical of ZES (multiple ulcers, often beyond the duodenal bulb) and allows biopsy to exclude malignancy.

5. Genetic Testing

If a patient has a personal or family history suggestive of MEN 1, testing for mutations in the MEN1 gene is recommended.

Treatment Options

Therapy aims to control acid hypersecretion, heal ulcers, and eradicate or control the gastrinoma.

Medical Management

• Proton pump inhibitors (PPIs) – high‑dose regimens (e.g., omeprazole 60 mg daily or equivalent) are the cornerstone, often required lifelong ^[3].
• H2‑receptor antagonists (ranitidine, famotidine) may be added for breakthrough symptoms, but PPIs are more effective.
• Antibiotic therapy for H. pylori if infection is present – eradication reduces ulcer recurrence.
• Somatostatin analogs (octreotide, lanreotide) – suppress gastrin secretion and may shrink tumors, especially in metastatic disease.
• Chemotherapy or targeted therapy (everolimus, sunitinib) – reserved for unresectable or progressive metastatic gastrinomas.

Surgical Options

• Localized tumor resection – curative if the gastrinoma is solitary and confined to the duodenum or pancreas.
• Enucleation – removal of small, well‑encapsulated tumors.
• Pancreaticoduodenectomy (Whipple procedure) – indicated for large or invasive pancreatic gastrinomas.
• Debulking surgery – may improve symptom control in metastatic disease when complete resection is impossible.

Home & Lifestyle Measures

• Take PPIs exactly as prescribed; do not skip doses.
• Avoid NSAIDs, aspirin, and other ulcer‑causing drugs unless advised otherwise.
• Limit alcohol and quit smoking – both increase ulcer risk.
• Eat smaller, more frequent meals; avoid extremely spicy or fatty foods that can exacerbate pain.
• Maintain a healthy weight and stay hydrated, especially if diarrhea is prominent.

Prevention Tips

While you cannot prevent a gastrinoma that is genetically determined, you can reduce the likelihood of ulcer complications and support overall gastrointestinal health:

• Screen for and treat H. pylori infection if you have a history of ulcers.
• Limit or avoid chronic NSAID use; use acetaminophen for pain when appropriate.
• Adopt a diet rich in fruits, vegetables, whole grains, and lean protein.
• Manage stress through regular exercise, mindfulness, or counseling – stress can worsen ulcer symptoms.
• If you have a family history of MEN 1, undergo genetic counseling and periodic screening as recommended by a specialist.
• Follow up regularly with your gastroenterologist or endocrinologist to monitor gastrin levels and tumor status.

Emergency Warning Signs

Key Take‑aways

Zollinger‑Ellison gastric pain is a hallmark of a rare, gastrin‑secreting tumor that creates excessive stomach acid. Prompt recognition, thorough diagnostic work‑up, and aggressive acid suppression are essential to prevent ulcer complications and to manage the underlying tumor. While lifelong medication is often required, surgery can be curative when the tumor is localized. Patients should be educated on warning signs that necessitate urgent care, and those with a family history of endocrine tumors should consider genetic counseling.

---

References:

1. Mayo Clinic. Zollinger‑Ellison syndrome. https://www.mayoclinic.org. Accessed May 2026.
2. NIH National Institute of Diabetes and Digestive and Kidney Diseases. Multiple endocrine neoplasia type 1. https://www.niddk.nih.gov. Accessed May 2026.
3. Cleveland Clinic. Zollinger‑Ellison syndrome treatment. https://my.clevelandclinic.org. Accessed May 2026.
4. World Health Organization. Classification of endocrine tumors. WHO Press, 2022.
5. American College of Gastroenterology. Guideline for the management of peptic ulcer disease. Gastroenterology. 2023;165(4):1129‑1145.